Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
Distribution of Brain Sodium Accumulation Correlates with Disability in Multiple Sclerosis: A Cross-sectional 23Na MR Imaging Study.
Structure and Activity of the Acid Sensing Ion Channels.
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient.
Variables associated with patient activation in persons with multiple sclerosis.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: No.
Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles.
Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
New TYSABRI® data show earlier treatment and longer-term use result in significant reductions in MS disease activity
New Disease-Modifying Therapies and New Challenges for MS.
MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R.
Central nervous system lymphoma associated with natalizumab.
Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM).
Significance of Virchow-Robin Spaces in Patients Newly Diagnosed with Multiple Sclerosis: A Case-Control Study in an Arab Population.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.
Tumor-like multiple sclerosis.
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
Distraction adds to the cognitive burden in multiple sclerosis.
Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72.
Combined EPR and Molecular Modeling Study of PPI Dendrimers Interacting with Copper Ions: Effect of Generation and Maltose Decoration.
Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
135
136
137
138
139
140
141
142
143
…
next ›
last »